New Strong Sell Stocks for June 16th

ACRE, CWST and CCAP have been added to the Zacks Rank #5 (Strong Sell) List on June 16, 2026.

Zacks Investment Research • Jun 16, 2026

New Strong Sell Stocks for June 12th

CCAP, DAVA and RH have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2026.

Zacks Investment Research • Jun 12, 2026

Crescent Capital Group Closes Largest Fund in Firm's History with Fourth U.S. Direct Lending Fund, Raising $10.8 Billion in Investable Capital

LOS ANGELES & NEW YORK & BOSTON & CHICAGO--(BUSINESS WIRE)--Crescent Capital Group LP (“Crescent”), one of the leading alternative credit investment firms, announced today the successful final close of its fourth U.S. direct lending fund, Crescent Direct Lending Fund IV (“CDL Fund IV”), raising $10.8 billion in investable capital, including targeted leverage and separately managed accounts investing alongside the fund. CDL Fund IV represents the latest vintage in Crescent's lower middle market.

Business Wire • Jun 3, 2026

My Income Portfolio - Looking For Dividends

Dividend investing provides a consistent income stream, beneficial for those seeking passive income, while growth stocks may require selling shares to realize gains. Seeking dividend income does not rule out focusing on the growth of the portfolio's nominal value, thanks to many funds that see their NAV grow over time. These securities offer a dual advantage: immediate returns through regular, periodic distributions, and capital appreciation through long-term NAV increase.

Seeking Alpha • Jun 1, 2026

The High-Yield Stocks the Smart Money Is Buying Right Now

There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.

Benzinga • May 24, 2026

Crescent Capital BDC: 13% Yield And A Discount Too Deep To Ignore

Crescent Capital BDC trades near a 52-week low, offering a 13% yield and a deep 0.61x price-to-book discount. CCAP's first-lien-heavy, diversified portfolio and recent management fee reductions support strong NII-to-dividend coverage at 113.5%. Nonaccruals rose to 3.6% of portfolio value, mainly in healthcare, but management actively manages these with meaningful control.

Seeking Alpha • May 19, 2026

Crescent Capital BDC Q1 Earnings Call Highlights

Crescent Capital BDC NASDAQ: CCAP reported a more difficult first quarter as higher non-accruals, lower base rates and broader credit-market volatility weighed on earnings and net asset value, prompting management to lower fees and reset the company's base dividend.

MarketBeat • May 14, 2026

Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Transcript

Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 14, 2026

Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends

LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or the “Company”) (NASDAQ: CCAP) today reported net investment income of $0.42 per share and net income of ($0.42) per share for the quarter ended March 31, 2026. Net asset value (NAV) per share was $18.27 at March 31, 2026. Subsequent to quarter end, the Company reduced its fee structure, lowering its base management fee from 1.25% to 1.00% and its incentive fee from 17.5% to 15.0%, effective April 1, 2026, further aligning interests with shareholders and supporting the durability of its earnings profile.

GlobeNewsWire • May 13, 2026

Crescent Capital BDC (CCAP) Tops Q1 Earnings Estimates

Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.45 per share a year ago.

Zacks Investment Research • May 13, 2026